Oxford University Hospitals says emissions linked to inhalers given to patients have reduced by 18%.
When baby Sidrah Isaacs was born, she appeared well. At around 6 weeks of age, her mother, Sasha Leigh, began to notice concerning symptoms, including a silent cough, a weak cry, and breathing ...
Oxford University Hospitals NHS Foundation Trust is making a move towards greener emissions by switching to lower-carbon ...
DIGITAL COPD inhaler training reduced technique errors and improved assessment of inspiratory capacity in a new study. COPD ...
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 ...
Despite guidelines recommending daily controller inhalers as the best treatment for asthma, new UCLA-led research finds that ...
Afrezza Inhaler Afrezza inhaler. Afrezza Inhaled insulin Afrezza Inhaler in Hand Afrezza inhaler in hand. Enables dosing at ...
U.S. Food and Drug Administration (FDA) has approved Afrezza Inhalation Powder for use in children and adolescents aged 6 and ...
New analyses examine Afrezza across pediatric A1c and efficacy, patient treatment satisfaction, use with AID algorithms and investigator-led ...
NHS health expert Dr Ranj Singh has issued important advice to asthma sufferers who use a blue inhaler. The doctor appeared on today's (May 18) episode of BBC's Morning Live to urge people who rely on ...
13:54, Mon, May 18, 2026 Updated: 14:05, Mon, May 18, 2026 NHS health expert Dr Ranj Singh has issued vital guidance to asthma sufferers who rely on a blue inhaler. The doctor appeared on today's (May ...
New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26% fall in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results